DIAZABICYCLIC CENTRAL NERVOUS SYSTEM ACTIVE AGENTS
申请人:Schrimpf R. Michael
公开号:US20080097094A1
公开(公告)日:2008-04-24
Compounds of formula I
pharmaceutical compositions of these compounds, and use of said compositions to control synaptic transmission in mammals.
化合物I的配方药物组合物,以及使用该组合物来控制哺乳动物的突触传递。
Octahydropyrrolo[3,4-<i>c</i>]pyrrole: A Diamine Scaffold for Construction of Either α4β2 or α7-Selective Nicotinic Acetylcholine Receptor (nAChR) Ligands. Substitutions that Switch Subtype Selectivity
作者:William H. Bunnelle、Karin R. Tietje、Jennifer M. Frost、Dan Peters、Jianguo Ji、Tao Li、Marc J. C. Scanio、Lei Shi、David J. Anderson、Tino Dyhring、Jens H. Grønlien、Hilde Ween、Kirsten Thorin-Hagene、Michael D. Meyer
DOI:10.1021/jm900249k
日期:2009.7.23
A series of 5-(pyridine-3-yl)octahydropyrrolo[3,4-c]pyrroles have been prepared that exhibit high affinity to alpha 4 beta 2 and/or alpha 7 nicotinic acetylcholine receptors (nAChRs). Simple substitution patterns have been identified that allow construction of ligands that are highly selective for either nAChR subtype. The effects of substitution on subtype selectivity provide some insight into the differences in the ligand binding domains of the alpha 4 beta 2 and alpha 7 receptors, especially in regions removed from the cation binding pocket.